Skip to main content

Table 2 Symptom scores All scores were obtained using a 5 category verbal rating scale score (scores; 1–5). All results are given as mean (SD). No significant differences in scores were observed between trial days.

From: Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study

 

Trial day 2

Trial day 3

Trial day 4

Pain

2.8 (0.7)

2.2 (1.1)

2.2 (1,1)

Nausea

1.7 (1.0)

1.7 (1.1)

1.8 (0.9)

Sedation

3.4 (1.2)

3.4 (1.0)

3.2 (1.1)